- Citations, last 5 years
- 39
- Works, last 5 years
- 4
- h-index
- 28
- Scientists listed
- 1
- Grants since 2016
- 1
Grants received
2022–2025 · research · R41
New anti-glioblastoma metabolic compounds with high potential for Blood Brain Barrier penetration
Krzysztof Reiss · SignPath Pharma (United States) · funded by National Institutes of Health
